Vessels of death or life.
Jain
R K
RK
University of Leuven, Belgium.
Carmeliet
P F
PF
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy; D002908:Chronic Disease; D016228:Endothelial Growth Factors / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008222:Lymphokines / Q000009:adverse effects / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000188:drug therapy; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy; D009389:Neovascularization, Pathologic; D018919:Neovascularization, Physiologic; D019636:Neurodegenerative Diseases / Q000188:drug therapy; D012164:Retinal Diseases / Q000188:drug therapy; D013927:Thrombosis / Q000188:drug therapy; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D020533:Angiogenesis Inhibitors; D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors